Submission of Annual Report for the Financial Year 2024-25 Pursuant to Regulation 34 and other relevant provisions of the SEBI (Listing Obligations & Disclosure Requirements), 2015.
Reg. 34 (1) Annual Report.
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Venmax Drugs & Pharmaceuticals Ltd. on 6ix
Earlier from Venmax Drugs & Pharmaceuticals
- Board Meeting Outcome for Outcome Of The Board Meeting
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 25 2025
- Closure of Trading Window
- Board Meeting Intimation for Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 16 2025
Later from Venmax Drugs & Pharmaceuticals
- Board Meeting Outcome for Revised Outcome Of Board Meeting
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 03 2025
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 26 2025
- Shareholder Meeting / Postal Ballot-Outcome of AGM
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 27 2025
Follow Venmax Drugs & Pharmaceuticals into a list and get an email when it puts out news.
Follow Venmax Drugs & Pharmaceuticals